| Quarter | Score |
|---|---|
| 2013-Q2 | 49.6 |
| 2013-Q3 | 54.2 |
| 2013-Q4 | 49.5 |
| 2014-Q1 | 49.6 |
| 2014-Q2 | 48.6 |
| 2014-Q3 | 49.9 |
| 2018-Q1 | 53.2 |
| 2018-Q2 | 52.7 |
| 2018-Q3 | 52.0 |
| 2019-Q2 | 52.7 |
| 2022-Q1 | 49.6 |
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.2 |
| 2023-Q1 | 49.8 |
| 2023-Q2 | 63.5 |
| 2023-Q3 | 48.1 |
| 2023-Q4 | 36.1 |
| 2024-Q1 | 70.8 |
| 2024-Q2 | 52.9 |
| 2024-Q3 | 54.5 |
| 2024-Q4 | 54.4 |
| 2025-Q1 | 54.8 |
| 2025-Q2 | 54.4 |
| 2025-Q3 | 53.7 |
| 2025-Q4 | 54.4 |
| 2026-Q1 | 72.3 |
| 2026-Q2 | 77.4 |
Solid consensus with smart money net adding at reasonable prices
Within 7.0% of funds' estimated purchase price
2 of 16 tracked funds hold MCO. Avg conviction: 4.7%. Net holding. First tracked at $436.93 (current +7.0% vs tracked).
Oakcliff Capital Partners has 5.7% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oakcliff Capital Partners | 5.7% | New Buy |
| Berkshire Hathaway | 3.7% | Hold |